Skip to content

SVODQWLQNCGPQM-UHFFFAOYSA-N

C34H43ClF3N7O6S — CID 139389154

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACtert-butyl 4-[2-[[6-[[2-chloro-6-[3-[3-[1-(trifluoromethyl)cyclopropyl]propoxy]pyrazol-1-yl]pyridine-3-carbonyl]sulfamoyl]-2-pyridinyl]amino]ethyl]-2,2-dimethylpyrrolidine-1-carboxylate
SMILESCC(C)(C)OC(=O)N1CC(CCNc2cccc(S(=O)(=O)NC(=O)c3ccc(-n4ccc(OCCCC5(C(F)(F)F)CC5)n4)nc3Cl)n2)CC1(C)C
InChIInChI=1S/C34H43ClF3N7O6S/c1-31(2,3)51-30(47)44-21-22(20-32(44,4)5)12-17-39-24-8-6-9-27(40-24)52(48,49)43-29(46)23-10-11-25(41-28(23)35)45-18-13-26(42-45)50-19-7-14-33(15-16-33)34(36,37)38/h6,8-11,13,18,22H,7,12,14-17,19-21H2,1-5H3,(H,39,40)(H,43,46)
InChIKeySVODQWLQNCGPQM-UHFFFAOYSA-N
MW770.28 g/mol
LogP6.77
Rot. Bonds13

About SVODQWLQNCGPQM-UHFFFAOYSA-N

SVODQWLQNCGPQM-UHFFFAOYSA-N (PubChem CID 139389154) has the molecular formula C34H43ClF3N7O6S and a molecular weight of 770.28 g/mol. Its IUPAC name is tert-butyl 4-[2-[[6-[[2-chloro-6-[3-[3-[1-(trifluoromethyl)cyclopropyl]propoxy]pyrazol-1-yl]pyridine-3-carbonyl]sulfamoyl]-2-pyridinyl]amino]ethyl]-2,2-dimethylpyrrolidine-1-carboxylate.

Molecular Properties

Compound NameSVODQWLQNCGPQM-UHFFFAOYSA-N
PubChem CID139389154
Molecular FormulaC34H43ClF3N7O6S
Molecular Weight770.28 g/mol
Exact Mass769.26
IUPAC Nametert-butyl 4-[2-[[6-[[2-chloro-6-[3-[3-[1-(trifluoromethyl)cyclopropyl]propoxy]pyrazol-1-yl]pyridine-3-carbonyl]sulfamoyl]-2-pyridinyl]amino]ethyl]-2,2-dimethylpyrrolidine-1-carboxylate
SMILESCC(C)(C)OC(=O)N1CC(CCNc2cccc(S(=O)(=O)NC(=O)c3ccc(-n4ccc(OCCCC5(C(F)(F)F)CC5)n4)nc3Cl)n2)CC1(C)C
InChIInChI=1S/C34H43ClF3N7O6S/c1-31(2,3)51-30(47)44-21-22(20-32(44,4)5)12-17-39-24-8-6-9-27(40-24)52(48,49)43-29(46)23-10-11-25(41-28(23)35)45-18-13-26(42-45)50-19-7-14-33(15-16-33)34(36,37)38/h6,8-11,13,18,22H,7,12,14-17,19-21H2,1-5H3,(H,39,40)(H,43,46)
InChIKeySVODQWLQNCGPQM-UHFFFAOYSA-N
XLogP6.77
TPSA157.64 Ų
H-Bond Donors2
H-Bond Acceptors11
Rotatable Bonds13
Heavy Atoms52
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500770.28
LogP ≤ 56.77
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze SVODQWLQNCGPQM-UHFFFAOYSA-N with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of SVODQWLQNCGPQM-UHFFFAOYSA-N?
The IUPAC name of SVODQWLQNCGPQM-UHFFFAOYSA-N (CID 139389154) is tert-butyl 4-[2-[[6-[[2-chloro-6-[3-[3-[1-(trifluoromethyl)cyclopropyl]propoxy]pyrazol-1-yl]pyridine-3-carbonyl]sulfamoyl]-2-pyridinyl]amino]ethyl]-2,2-dimethylpyrrolidine-1-carboxylate.
What is the SMILES notation for SVODQWLQNCGPQM-UHFFFAOYSA-N?
The canonical SMILES for SVODQWLQNCGPQM-UHFFFAOYSA-N is CC(C)(C)OC(=O)N1CC(CCNc2cccc(S(=O)(=O)NC(=O)c3ccc(-n4ccc(OCCCC5(C(F)(F)F)CC5)n4)nc3Cl)n2)CC1(C)C.
What is the InChIKey of SVODQWLQNCGPQM-UHFFFAOYSA-N?
The InChIKey is SVODQWLQNCGPQM-UHFFFAOYSA-N. The full InChI is InChI=1S/C34H43ClF3N7O6S/c1-31(2,3)51-30(47)44-21-22(20-32(44,4)5)12-17-39-24-8-6-9-27(40-24)52(48,49)43-29(46)23-10-11-25(41-28(23)35)45-18-13-26(42-45)50-19-7-14-33(15-16-33)34(36,37)38/h6,8-11,13,18,22H,7,12,14-17,19-21H2,1-5H3,(H,39,40)(H,43,46).
What are the key properties of SVODQWLQNCGPQM-UHFFFAOYSA-N?
SVODQWLQNCGPQM-UHFFFAOYSA-N has a molecular weight of 770.28 g/mol, XLogP of 6.77, 13 rotatable bonds, 2 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for SVODQWLQNCGPQM-UHFFFAOYSA-N is sourced from PubChem (CID 139389154), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.